Endo drops after FTC sues over 'Pay-to-delay' deals
March 31, 2016 at 14:14 PM EDT
Shares of Endo Pharmaceutical fell in morning trading in New York after the Federal Trade Commission announced that it was suing the company for blocking generic versions of its Opana ER and Lidoderm.
